RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) on January 21 and set a price target ...
In a report released on January 16, Arun Viswanathan from RBC Capital maintained a Hold rating on GrafTech International (EAF – Research ...
RBC Capital Markets adjusted its price target for Westlake Chemical (NYSE:WLK) stock, reducing it to $147.00 from the ...